All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

324

Reset

324 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • Zelenectide pevedotinBT8009Phase 25 trials

    BicycleTx Limited · Breast Cancer, Non-Small Cell Lung Cancer, Advanced Solid Tumors

  • AB928Etrumadenant, ETRUMAPhase 24 trials

    Arcus Biosciences, Inc. · Lung Cancer, Advanced or Metastatic Non-Small-Cell Lung Cancer, Resectable Non-Small-Cell Lung Cancer

  • ABSK043Phase 24 trials

    Abbisko Therapeutics Co, Ltd · Non-Small Cell Lung Cancer, Non-Small Cell Lung Cancer With EGFR-mutated and PD-L1 Positive, HER2-Gastric/Gastroesophageal Junction Cancer

  • BenmelstobartPhase 24 trials

    Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. · Alveolar Soft Part Sarcoma, Non-Small Cell Lung Cancer, Gastroesophageal Adenocarcinoma

  • EnvafolimabPhase 24 trials

    3D Medicines (Sichuan) Co., Ltd. · Biliary Tract Neoplasms, Solid Tumor, Solid Tumors

  • GecacitinibPhase 24 trials

    Suzhou Zelgen Biopharmaceuticals Co.,Ltd · Lymphoma, Non-small Cell Lung Cancer, Advanced Solid Tumor

  • IL-2MDNA11, Interleukin-2 -albuminPhase 24 trials

    Grit Biotechnology · Advanced Solid Tumor, Unresectable Solid Tumor, Clear Cell Renal Cell Carcinoma

  • TUB-040Phase 24 trials

    Gilead Sciences · Ovarian Cancer, Non-small Cell Lung Cancer, Uterine Endometrial Cancer

  • UbamatamabREGN4018Phase 24 trials

    Regeneron · Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer

  • VS-7375Phase 24 trials

    Verastem, Inc. · G12D Mutated KRAS, Colorectal Cancer, Pancreatic Ductal Adenocarcinoma (PDAC)

  • ADCAntibody-drug conjugate, ADCE-D01Phase 23 trials

    MBrace Therapeutics · Prostate Cancer Castration-resistant Prostate Cancer, Breast Cancer, Colo-rectal Cancer

  • AK146D1Phase 23 trials

    Akeso · Advanced Non Small Cell Lung Cancer (NSCLC), Advanced Breast Cancer, Urothelial Carcinoma (UC)

  • AlisertibPB-8237, MLN8237Phase 23 trials

    Puma Biotechnology, Inc. · Hormone Receptor Positive HER-2 Negative Breast Cancer, Metastatic Breast Cancer, Recurrent Breast Cancer

  • AnvumetostatAMG 193Phase 23 trials

    Amgen · Advanced MTAP-null Solid Tumors, MTAP-deleted NSCLC, MTAP-null Non-Small-Cell Lung Cancer

  • AZD4205Phase 23 trials

    Dizal Pharmaceuticals · Non-small Cell Lung Cancer, Peripheral T-cell Lymphoma, Peripheral T Cell Lymphoma

  • BoserolimabMK-5890Phase 23 trials

    Merck & Co. · Carcinoma, Non-Small-Cell Lung, Small Cell Lung Cancer

  • BT5528nuzefatide pevedotinPhase 23 trials

    BicycleTx Limited · Advanced Solid Tumors, Advanced Solid Tumor Historically Known for High EphA2 Expression, Urothelial Cancer

  • GV20-0251Phase 23 trials

    GV20 Therapeutics · Endometrial Carcinoma (EC), Squamous Head and Neck Carcinoma, pMMR/MSS Adenocarcinoma of the Colon or Rectum

  • IAP0971Phase 23 trials

    SUNHO(China)BioPharmaceutical CO., Ltd. · Advanced Malignant Neoplasm, Advanced or Metastatic Non-small Cell Lung Cancer, Bladder Cancer

  • JDQ443OpnurasibPhase 23 trials

    Novartis · Locally Advanced or Metastatic KRAS G12C-mutated NSCLC With a PD-L1 Expression <1% or a PD-L1 Expression ≥ 1% and an STK11 Co-mutation, Locally Advanced or Metastatic KRAS G12C-mutated Non-small Cell Lung Cancer, Advanced Solid Tumors Harboring the KRAS G12C Mutation

  • MCLA-129Phase 23 trials

    Betta Pharmaceuticals Co., Ltd. · Non-Small Cell Lung Cancer, Solid Tumor, Head and Neck Cancer

  • PD-L1 t-haNKPhase 23 trials

    ImmunityBio, Inc. · Pancreatic Cancer, Non-Small Cell Lung Cancer, Small Cell Lung Cancer

  • REGN10597PD-1-IL2Ra-IL2 immunotherapyPhase 23 trials

    Regeneron · Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer

  • REGN7075marlotamigPhase 23 trials

    Regeneron · Non Small Cell Lung Cancer, Advanced Non Small Cell Lung Cancer, Metastatic Non Small Cell Lung Cancer

  • RMC-6291ElironrasibPhase 23 trials

    Revolution Medicines, Inc. · Non-Small Cell Lung Cancer, NSCLC, KRAS, NRAS, HRAS-mutated NSCLC, KRAS G12C-mutated Solid Tumors, Lung Cancer

  • RMC-9805Phase 23 trials

    Revolution Medicines, Inc. · PDAC, Colorectal Cancer, CRC

  • roginolisibIOA-244Phase 23 trials

    iOnctura · Myelofibrosis (MF), Non-Squamous Non-Small Cell Lung Cancer (NSCLC), Advanced Non Squamous NSCLC

  • SHR-7787Phase 23 trials

    Shanghai Hengrui Pharmaceutical Co., Ltd. · Malignant Solid Tumors, Limited-stage Small-cell Lung Cancer, Advanced Solid Tumors

  • SKB118Phase 23 trials

    Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. · Non-Squamous Non-Small Cell Lung Cancer, Advanced Solid Tumors, NSCLC

  • SSGJ-706Phase 23 trials

    Shenyang Sunshine Pharmaceutical Co., LTD. · Non Small Cell Lung Cancer, Gastric/Gastroesophageal Junction Adenocarcinoma, Metastatic Colorectal Cancer (CRC)

  • SYS6090Phase 23 trials

    CSPC Megalith Biopharmaceutical Co.,Ltd. · HCC - Hepatocellular Carcinoma, Non-Small Cell Lung Cancer, Small Cell Lung Cancer

  • Tmod CAR T-cell TherapyA2B530, A2B694Phase 23 trials

    A2 Biotherapeutics Inc. · Solid Tumor, Adult, Colorectal Cancer, Colorectal Adenocarcinoma

  • valemetostat tosylateDS-3201bPhase 23 trials

    Daiichi Sankyo · Non-small Cell Lung Cancer, Lung Cancer, Relapsed/Refractory Peripheral T-Cell Lymphoma

  • WSD0922-FUWSD0922Phase 23 trials

    Wayshine Biopharm, Inc. · Non Small Cell Lung Cancer (NSCLC), EGFR Mutation Positive Advanced Non-Small Cell Lung Cancer, Non Small Cell Lung Cancer

  • ABSK061Phase 22 trials

    Abbisko Therapeutics Co, Ltd · HER2-Gastric/Gastroesophageal Junction Cancer, Urothelial Carcinoma, Non-Small Cell Lung Cancer

  • AK129Phase 22 trials

    Akeso · Non-small Cell Lung Cancer Stage IIIB/IV, Head and Neck Squamous Cell Carcinoma (HNSCC), Colorectal Adenocarcinoma

  • AK138D1Phase 22 trials

    Akeso · Non-Small Cell Lung Cancer, Breast Cancer

  • ALK201Phase 22 trials

    Shanghai Allink Biotherapeutics Co., Ltd. · NSCLC (Advanced Non-small Cell Lung Cancer), Advanced Cancer, Advanced Solid Tumors

  • Ametinib MesylatePhase 22 trials

    Shanghai Hengrui Pharmaceutical Co., Ltd. · Advanced Solid Tumors, Non-small Cell Lung Cancer (NSCLC)

  • Shanghai Juncell Therapeutics · Non Small Cell Lung Cancer, Melanoma

  • AZD0171MSC-1Phase 22 trials

    AstraZeneca · Non-small Cell Lung Cancer, Locally Advanced or Metastatic Solid Tumours

  • B1962Phase 22 trials

    Tasly Biopharmaceuticals Co., Ltd. · Recurrent Platinum-resistant Epithelial Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Cervical Cancers

  • BNT326Phase 22 trials

    BioNTech SE · Advanced Solid Tumor, Non-small Cell Lung Cancer

  • CAB-AXL-ADCBA3011Phase 22 trials

    BioAtla, Inc. · Non-Small-Cell Lung Cancer, Undifferentiated Pleomorphic Sarcoma, Myxofibrosarcoma

  • Carboplatin AUC-5Phase 22 trials

    Inhibrx Biosciences, Inc · Solid Tumor, Non-Small Cell Lung Cancer, Head and Neck Cancer

  • Dositinib mesylatePhase 22 trials

    Henan Genuine Biotech Co., Ltd. · Non-Small Cell Lung Cancer

  • DS-3939aPhase 22 trials

    Daiichi Sankyo · Solid Tumor, Locally Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer

  • DSP107Phase 22 trials

    Kahr Bio Australia Pty Ltd · Colorectal Cancer, Advanced Solid Tumor, Non Small Cell Lung Cancer

  • DZD6008Phase 22 trials

    Dizal Pharmaceuticals · Non-Small Cell Lung Cancer, Non Small Cell Lung Cancer

  • EB-DART-NK01DLL3, CD56 CAR-NK cellsPhase 22 trials

    Beijing Biotech · Small Cell Lung Cancer (SCLC), Relapsed/Refractory SCLC, Extensive-stage SCLC

NewerPage 4 of 7Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.